| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |